🇺🇸 FDA
Pipeline program

Dupilumab

SMART-NS 01

Phase 2 mab active

Quick answer

Dupilumab for Nephrotic Syndrome in Children is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Nephrotic Syndrome in Children
Phase
Phase 2
Modality
mab
Status
active

Clinical trials